ACIP Dismissals Spark Regulatory Uncertainty as ADCs Surge in Biopharma Innovation
The action has sent shockwaves through the public health and vaccine development communities, raising concerns about regulatory continuity and future vaccine rollouts, according to GlobalData.
ACIP Dismissals Spark Regulatory Uncertainty As AD | 08/07/2025 | By Darshana | 247
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy